Report on the risk assessment of 2CI, 2CT2 and 2CT7 in the framework of the joint action on new synthetic drugs
6
About the EMCDDA
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is one of the decentralised agencies set up by the European Union to carry out specialised technical or scientific work.
Its role is to gather, analyse and disseminate objective, reliable and comparable information on drugs and drug addiction and, in doing so, provide its audiences with a sound and evidencebased picture of the drug phenomenon at European level.
Among the Centre’s target groups are policymakers who use this information to help formulate coherent national and Community drug strategies. Also served are professionals and researchers working in the drugs field and, more broadly, the European media and general public.
EMCDDA risk assessments are publications examining the health and social risks of individual synthetic drugs on the basis of research carried out by the agency and its partners.